Jamie Harrell | Investor Relations |
Peter Greenleaf | Chief Executive Officer |
Joe Miller | Chief Financial Officer |
Will Soghikian | Leerink Partners |
Ed Arce | H.C. Wainwright |
David Martin | Bloom Burton |
Farzin Haque | Jefferies |
Justin Kim | Oppenheimer |
Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]